Detalhe da pesquisa
1.
Decreased neutrophil function in newly diagnosed multiple myeloma patients is restored with lenalidomide therapy.
Eur J Haematol
; 2024 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38553844
2.
Impact of 1q gains on treatment outcomes of patients with newly diagnosed multiple myeloma in a real-world Swedish population receiving modern treatment.
Eur J Haematol
; 111(3): 391-399, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37271732
3.
Epidemiology and clinical outcomes of light-chain amyloidosis in Sweden: A nationwide population-based study.
Eur J Haematol
; 111(5): 697-705, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37533343
4.
Computed tomography with adjusted dose for body mass index may be superior to whole-body radiography especially in elderly patients with multiple myeloma.
Acta Radiol
; 64(5): 1896-1903, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36760071
5.
Longitudinal minimal residual disease assessment in multiple myeloma patients in complete remission - results from the NMSG flow-MRD substudy within the EMN02/HO95 MM trial.
BMC Cancer
; 22(1): 147, 2022 Feb 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35123422
6.
Carfilzomib and dexamethasone maintenance following salvage ASCT in multiple myeloma: A randomised phase 2 trial by the Nordic Myeloma Study Group.
Eur J Haematol
; 108(1): 34-44, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34536308
7.
Burden of Treatment-Induced Peripheral Neuropathy in Patients with Multiple Myeloma in Sweden.
Acta Haematol
; 144(5): 519-527, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33631745
8.
Health-related quality of life in transplant ineligible newly diagnosed multiple myeloma patients treated with either thalidomide or lenalidomide-based regimen until progression: a prospective, open-label, multicenter, randomized, phase 3 study.
Haematologica
; 105(6): 1650-1659, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31515355
9.
Transcriptome-wide association study of multiple myeloma identifies candidate susceptibility genes.
Hum Genomics
; 13(1): 37, 2019 08 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-31429796
10.
Outcome and characteristics of non-measurable myeloma: A cohort study with population-based data from the Swedish Myeloma Registry.
Eur J Haematol
; 104(5): 376-382, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-31733147
11.
Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma.
N Engl J Med
; 374(17): 1621-34, 2016 Apr 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-27119237
12.
Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma.
N Engl J Med
; 373(13): 1207-19, 2015 Sep 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-26308596
13.
Safety and efficacy of pomalidomide plus low-dose dexamethasone in STRATUS (MM-010): a phase 3b study in refractory multiple myeloma.
Blood
; 128(4): 497-503, 2016 07 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-27226434
14.
Melphalan, prednisone, and lenalidomide versus melphalan, prednisone, and thalidomide in untreated multiple myeloma.
Blood
; 127(9): 1109-16, 2016 Mar 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-26802176
15.
Impact of daratumumab-based induction on stem cell collection parameters in Swedish myeloma patients.
Haematologica
; 108(2): 610-614, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36200424
16.
Impact of prior therapy on the efficacy and safety of oral ixazomib-lenalidomide-dexamethasone vs. placebo-lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma in TOURMALINE-MM1.
Haematologica
; 102(10): 1767-1775, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28751562
17.
Incidence, characteristics, and outcome of solitary plasmacytoma and plasma cell leukemia. Population-based data from the Swedish Myeloma Register.
Eur J Haematol
; 99(3): 216-222, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28544116
18.
Adverse event management in patients with relapsed and refractory multiple myeloma taking pomalidomide plus low-dose dexamethasone: A pooled analysis.
Eur J Haematol
; 99(3): 199-206, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28504846
19.
Robust isolation of malignant plasma cells in multiple myeloma.
Blood
; 123(9): 1336-40, 2014 Feb 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-24385542
20.
Cost effectiveness of pomalidomide in patients with relapsed and refractory multiple myeloma in Sweden.
Acta Oncol
; 55(5): 554-60, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-27123742